Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss attributable to NaturalShrimp Inc. $ (86,297,748) $ (3,580,454)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation expense 1,307,038 346,437
Amortization expense 881,500
Amortization of debt discount 2,616,364 47,273
Change in fair value of derivative liability 116,000 29,000
Change in fair value of warrant liability (1,987,000)
Financing costs 1,890,072
Default penalty 41,112
Net loss attributable to non-controlling interest (5,729)
Forgiveness of PPP loan (103,200)
Gain on Vero Blue debt settlement (815,943)
Legal settlement 29,388,000
Shares issued for services 44,099,376 745,250
Changes in operating assets and liabilities:    
Accounts receivable (14,385)
Inventory (69,170)
Prepaid expenses and other current assets (1,506,207) (526,646)
Accounts payable (2,657,052) 325,264
Other accrued expenses (79,007) 117,957
Accrued expenses - related parties 200,000
Accrued interest 440,118 39,063
Accrued interest - related parties 16,000 44,096
Cash used in operating activitites (12,575,244) (2,377,377)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for machinery and equipment (1,452,652) (1,739,186)
Cash paid for asset acquisition with VeroBlue Farms, Inc. (5,000,000)
Cash received from Insurance settlement 917,210
Cash paid for patent acquisition with F & T (2,000,000)  
Cash paid for acquisition of shares of NCI (1,000,000)  
Cash paid for License Agreement (2,350,000)  
Cash paid for construction in process (1,629,813) (1,715,654)
CASH USED IN INVESTING ACTIVITIES (8,432,465) (7,537,630)
CASH FLOWS FROM FINANCING ACTIVITIES    
Payments on bank loan (214,852) (19,889)
Payments of notes payable (4,596,000)  
Payments on notes payable, related party (655,750) (72,000)
Repayment line of credit short-term (553,577)
Proceeds from PPP loan 103,200
Proceeds from issuance of common shares under equity agreeement 17,277,123
Proceeds from sale of Series B Convertible Preferred stock 3,250,000
Proceeds from convertible debentures 8,905,000 600,000
Escrow account in relation to the proceeds from convertible debenture 5,000,000
Payments on convertible debentures (421,486)
Proceeds from sale of Series E PS 1,348,000
Proceeds from sale of Series D PS 6,050,000
Redemption of Series D PS (3,513,504)
Shares issued upon exercise of warrants 11,000
Cash received in relation to Vista warrant settlement 50,000
Cash provided by financing activitites 22,585,954 9,961,311
NET CHANGE IN CASH 1,578,245 46,304
CASH AT BEGINNING OF YEAR 155,795 109,491
CASH AT END OF YEAR 1,734,040 155,795
INTEREST PAID 1,153,343 100,108
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Shares issued upon conversion of convertible debentures 421,486 551,021
Shares issued upon conversion of Preferred stock 2,880,000
Cancellation of Right of Use asset and Lease liability 275,400
Right of Use asset and Lease liability 332,566
Dividends in kind issued 278,400 134,442
Shares issued as consideration for Patent acquisition 5,000,000
Shares issued as consideration for acquisition of remaining NCI $ 2,000,000
Shares issued as consideration for Rights Agreement 4,762,376
Shares issued/to be issued, for legal settlement $ 29,388,000
Shares issued on Vista Warrant settlement 610,000
Note payable, related party, issued in place of Settlement Agreement $ 383,604
Notes payable, issued as consideration in VeroBlue Farms, Inc. asset acquisition 5,000,000
Shares payable, to be issued as finders fee in VeroBlue Farms, Inc. asset acquisition $ 136,000